VYNE Therapeutics Ownership | Who Owns VYNE Therapeutics?


OverviewRevenueFinancialsChart

VYNE Therapeutics Ownership Summary


VYNE Therapeutics is owned by 7.78% institutional investors, 4.33% insiders, and 87.89% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 1.99% of VYNE shares. Kennedy Micro Cap Opportunities is the top mutual fund, with 2.96% of its assets in VYNE Therapeutics shares.

VYNE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVYNE Therapeutics7.78%4.33%87.89%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp851.35K1.99%$285.20K
Acorn capital advisors586.57K1.37%$199.43K
Shay capital492.58K1.15%$165.01K
Acadian asset management446.41K1.04%$148.00K
Ikarian capital290.00K0.68%$97.15K
Two sigma investments, lp220.79K0.52%$73.96K
Vanguard group190.38K0.45%$63.78K
Jane street group147.12K0.34%$49.28M
Geode capital management137.12K0.32%$45.94K
Boothbay fund management106.46K0.25%$35.66K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Acorn capital advisors586.57K0.10%$199.43K
Harvest investment services51.33K0.02%$84.69K
Rangeley capital50.00K0.01%$16.75K
Shay capital492.58K0.01%$165.01K
Ikarian capital290.00K0.01%$97.15K
Staley capital advisers36.47K0.01%$122.18K
Corsair capital management50.00K0.00%$16.75K
Baker bros. advisors lp851.35K0.00%$285.20K
Gsa capital partners llp35.92K0.00%$12.00K
Bridgeway capital management76.96K0.00%$25.78K

Top Buyers

HolderShares% AssetsChange
Baker bros. advisors lp851.35K0.00%851.35K
Shay capital492.58K0.01%492.58K
Acadian asset management446.41K0.00%424.00K
Two sigma investments, lp220.79K0.00%220.79K
Two sigma advisers, lp56.60K-56.60K

Top Sellers

HolderShares% AssetsChange
Eventide asset management---1.39M
Cormorant asset management, lp---1.37M
Adage capital partners gp---644.13K
Dafna capital management---636.10K
Kennedy capital management---570.74K

New Positions

HolderShares% AssetsChangeValue
Baker bros. advisors lp851.35K0.00%851.35K$285.20K
Two sigma investments, lp220.79K0.00%220.79K$73.96K
Two sigma advisers, lp56.60K-56.60K$18.96K
Harvest investment services51.33K0.02%51.33K$84.69K
Rangeley capital50.00K0.01%50.00K$16.75K

Sold Out

HolderChange
Cornerstone planning group-2.00
Northwestern mutual wealth management-11.00
Ashton thomas private wealth-19.00
Centerpoint advisors-350.00
Cwm-500.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202529-29.27%3,326,375-51.06%73.07%15-31.82%2-77.78%
Jun 30, 20254415.79%8,048,76812.39%186.70%22-1271.43%
Mar 31, 2025388.57%7,161,7611.37%166.10%2215.79%716.67%
Dec 31, 20241-36,472--1168.22%----
Sep 30, 20241-50.00%36,472-0.05%-1166.04%--100.00%--

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Kennedy Micro Cap Opportunities493.02K2.96%493.02K
Vanguard US Total Market Shares ETF373.32K2.45%-
Vanguard Total Stock Mkt Idx Inv365.33K2.19%-7.99K
AlphaCentric LifeSci Healthcare I310.50K2.11%-134.50K
AlphaCentric Life Sciences & Hlthcare I268.49K1.82%-42.02K
Alger LIfe Sciences Innovation Composite388.07K1.52%388.07K
Pleiades Small Cap Equity A149.44K0.90%149.44K
Vanguard Institutional Extnd Mkt Idx Tr130.10K0.78%8.12K
AZ Equity Biotechnology A-AZ EUR Acc91.08K0.55%2.50K
Bridgeway Ultra-Small Company76.96K0.39%25.00K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 15, 2025LEPORE PATRICK G-Buy$43.80K
Nov 15, 2023LEPORE PATRICK G-Buy$50.78K
Mar 20, 2023LEPORE PATRICK G-Buy$49.68K
Mar 20, 2023Harsch Mutya Chief Legal Officer and GCBuy$25.00K
Nov 30, 2021LEPORE PATRICK G-Buy$12.70K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q11-
2024 Q4--
2024 Q3--

VYNE Ownership FAQ


Who Owns VYNE Therapeutics?

VYNE Therapeutics shareholders are primarily institutional investors at 7.78%, followed by 4.33% insiders and 87.89% retail investors. The average institutional ownership in VYNE Therapeutics's industry, Biotech Stocks , is 45.24%, which VYNE Therapeutics falls below.

Who owns the most shares of VYNE Therapeutics?

VYNE Therapeutics’s largest shareholders are Baker bros. advisors lp (851.35K shares, 1.99%), Acorn capital advisors (586.57K shares, 1.37%), and Shay capital (492.58K shares, 1.15%). Together, they hold 4.51% of VYNE Therapeutics’s total shares outstanding.

Does Blackrock own VYNE Therapeutics?

BlackRock is not among the top 10 institutional shareholders of VYNE Therapeutics.

Who is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested?

Acorn capital advisors is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 586.57K VYNE Therapeutics shares, valued at 199.43K$.

Who is the top mutual fund holder of VYNE Therapeutics shares?

Kennedy Micro Cap Opportunities is the top mutual fund holder of VYNE Therapeutics shares, with 2.96% of its total shares outstanding invested in 493.02K VYNE Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools